Testing effectiveness (Phase 2)Study completedNCT00087685What this trial is testingRAD001 in Recurrent Endometrial Cancer PatientsWho this might be right forEndometrial Cancer M.D. Anderson Cancer Center 35
Testing effectiveness (Phase 2)Study completedNCT00928642What this trial is testingGleevec and Gemzar in Patients With Epithelial Ovarian CancerWho this might be right forOvarian CancerPrimary Peritoneal Cancer Henry M. Jackson Foundation for the Advancement of Military Medicine 8
Testing effectiveness (Phase 2)Active Not RecruitingNCT04034927What this trial is testingTesting the Addition of an Immunotherapy Drug, Tremelimumab, to the PARP Inhibition Drug, Olaparib, for Recurrent Ovarian, Fallopian Tube or Peritoneal CancerWho this might be right forFallopian Tube Endometrioid TumorFallopian Tube High Grade Serous AdenocarcinomaMalignant Ovarian Endometrioid Tumor+11 more National Cancer Institute (NCI) 61
Testing effectiveness (Phase 2)Study completedNCT02093598What this trial is testingPOEM STUDY: A Phase IIa Trial in Endometrial Carcinoma With TemsirolimusWho this might be right forCarcinoma, EndometrioidmTOR Protein MedSIR 10
Not applicableLooking for participantsNCT06689956What this trial is testingOutcomes of Low-Risk Endometrial Cancer With Isolated Tumor Cells in the Sentinel Lymph Nodes: A Prospective, Multicenter, Single-Arm Observational StudyWho this might be right forFIGO Grade 1 Endometrial Endometrioid AdenocarcinomaFIGO Grade 2 Endometrial Endometrioid AdenocarcinomaStage IA1 Endometrial Cancer FIGO 2023+1 more Mayo Clinic 212
Testing effectiveness (Phase 2)Looking for participantsNCT06463028What this trial is testingSapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial CancerWho this might be right forEndometrial Cancer Faeth Therapeutics 40
Testing effectiveness (Phase 2)Looking for participantsNCT06618235What this trial is testingTrial of THEO-260 in Ovarian Cancer PatientsWho this might be right forOvarian Cancer Theolytics Limited 44
Early research (Phase 1)Active Not RecruitingNCT05276973What this trial is testingTesting the Addition of Ipatasertib to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) for Stage III or IV Epithelial Ovarian CancerWho this might be right forFallopian Tube Endometrioid AdenocarcinomaFallopian Tube High Grade Serous AdenocarcinomaOvarian Endometrioid Adenocarcinoma+15 more National Cancer Institute (NCI) 25
Not applicableActive Not RecruitingNCT06213571What this trial is testingRemote Home-Based Exercise Program for Strength Training in Endometrial Cancer Survivors in Rural AreasWho this might be right forFIGO Grade 1 Endometrial Endometrioid AdenocarcinomaFIGO Grade 2 Endometrial Endometrioid AdenocarcinomaStage IA Uterine Corpus Cancer AJCC v8+1 more Mayo Clinic 80
Testing effectiveness (Phase 2)Active Not RecruitingNCT02834013What this trial is testingNivolumab and Ipilimumab in Treating Patients With Rare TumorsWho this might be right forAcinar Cell CarcinomaAdenoid Cystic CarcinomaAdrenal Cortical Carcinoma+91 more National Cancer Institute (NCI) 798
Large-scale testing (Phase 3)Active Not RecruitingNCT01167712What this trial is testingPaclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube CancerWho this might be right forFallopian Tube Endometrioid AdenocarcinomaFallopian Tube Mucinous AdenocarcinomaFallopian Tube Transitional Cell Carcinoma+27 more National Cancer Institute (NCI) 692
Early research (Phase 1)Study completedNCT00079430What this trial is testingPaclitaxel, Bevacizumab And Adjuvant Intraperitoneal Carboplatin in Treating Patients Who Had Initial Debulking Surgery for Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube CancerWho this might be right forBrenner TumorFallopian Tube CancerOvarian Clear Cell Cystadenocarcinoma+9 more National Cancer Institute (NCI) 113
Early research (Phase 1)Study completedNCT00005026What this trial is testingCombination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal CancerWho this might be right forOvarian CancerPrimary Peritoneal Cavity Cancer Gynecologic Oncology Group
Large-scale testing (Phase 3)Looking for participantsNCT05256225What this trial is testingTesting the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or CarcinosarcomaWho this might be right forEndometrial CarcinomaEndometrial Clear Cell AdenocarcinomaEndometrial Dedifferentiated Carcinoma+5 more National Cancer Institute (NCI) 360
Early research (Phase 1)Study completedNCT00006235What this trial is testingLiposomal Doxorubicin and Carboplatin in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal CancerWho this might be right forFallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer Gynecologic Oncology Group
Not applicableUnknownNCT00238342What this trial is testingProteomic Profiling in Diagnosing Ovarian Cancer in Patients Who Are Undergoing Surgery for an Abnormal Pelvic MassWho this might be right forFallopian Tube CancerOvarian Cancer Gynecologic Oncology Group 2,000
Early research (Phase 1)Study completedNCT00101972What this trial is testingRAV12 in Treating Patients With Metastatic or Recurrent AdenocarcinomaWho this might be right forCancer MacroGenics 53
Large-scale testing (Phase 3)Active Not RecruitingNCT03914612What this trial is testingTesting the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial CancerWho this might be right forEndometrial Clear Cell AdenocarcinomaEndometrial Dedifferentiated CarcinomaEndometrial Endometrioid Adenocarcinoma+13 more National Cancer Institute (NCI) 813
Early research (Phase 1)Study completedNCT00066651What this trial is testingImmunotoxin Therapy in Treating Patients With Advanced Solid TumorsWho this might be right forCervical CancerFallopian Tube CancerHead and Neck Cancer+5 more National Cancer Institute (NCI)
Early research (Phase 1)Ended earlyNCT03924245What this trial is testingOlaparib and Entinostat in Patients With Recurrent, Platinum-Refractory, Resistant Ovarian, Primary Peritoneal, Fallopian Tube CancersWho this might be right forFallopian Tube CancerFallopian Tube CarcinosarcomaFallopian Tube Clear Cell Adenocarcinoma+10 more Vanderbilt-Ingram Cancer Center 3